Skip to main content

Advertisement

Log in

MiRNA-338-3p Inhibits Neuroinflammation in the Corpus Callosum of LCV-LPS Rats Via STAT1 Signal Pathway

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Neuroinflammation is a common characteristic of intracranial infection (ICI), which is associated with the activation of astrocytes and microglia. MiRNAs are involved in the process of neuroinflammation. This study aimed to investigate the potential mechanism by which miR-338-3p negatively modulate the occurrence of neuroinflammation. We here reported that the decreased levels of miR-338-3p were detected using qRT-PCR and the upregulated expression of TNF-α and IL-1β was measured by ELISA in the cerebrospinal fluid (CSF) in patients with ICI. A negative association between miR-338-3p and TNF-α or IL-1β was revealed by Pearson correlation analysis. Sprague–Dawley (SD) rats were injected with LPS (50 μg) into left cerebral ventricule (LCV), following which the increased expression of TNF-α and IL-1β and the reduction of miR-338-3p expression were observed in the corpus callosum (CC). Moreover, the expression of TNF-α and IL-1β in the astrocytes and microglia in the CC of LCV-LPS rats were saliently inhibited by the overexpression of miR-338-3p. In vitro, cultured astrocytes and BV2 cells transfected with mimic-miR-338-3p produced less TNF-α and IL-1β after LPS administration. Direct interaction between miR-338-3p and STAT1 mRNA was validated by biological information analysis and dual luciferase assay. Furthermore, STAT1 pathway was found to be implicated in inhibition of neuroinflammation induced by mimic miR-338-3p in the astrocytes and BV2 cells. Taken together, our results suggest that miR-338-3p suppress the generation of proinflammatory mediators in astrocyte and BV2 cells induced by LPS exposure through the STAT1 signal pathway. MiR-338-3p could act as a potential therapeutic strategy to reduce the neuroinflammatory response.

Graphical Abstract

Diagram describing the cellular and molecular mechanisms associated with LPS-induced neuroinflammation via the miR-338-3p/STAT1 pathway. LPS binds to TLRs on astrocytes or microglia to activate the STAT1 pathway and upregulate the production of pro-inflammatory cytokines. However, miR-338-3p inhibits the expression of STAT1 and reduces the production of inflammatory mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data Availability

The datasets during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

ICI:

Intracranial infection

CSF:

Cerebrospinal fluid

PWM:

Periventricular white matter

PWMD:

PWM damage

CC:

Corpus callosum

CNS:

Central nervous system

LPS:

Lipopolysaccharide

LCV:

Left cerebral ventricule

NC:

Negative control reagent

AAV:

Adeno associated virus

STAT1:

Signal transducer and activator of transcription 1

TNF-α:

Tumour necrosis factor alpha

IL-1β:

Interleukin-1β

FBS:

Fetal bovine serum

DMEM:

Dulbecco’s modified eagle medium

PBS:

Phosphate-buffer saline

TBST:

Tris-buffered saline Tween-20

qRT-PCR:

Quantitative real-time polymerase chain reaction

SD rats:

Sprague–Dawley rats

SD:

Mean ± standard deviation

si:

Small interfering

WT:

Wild-type

MUT:

Mutant

References

Download references

Funding

This study was supported by Key Research and Development projects of the Ministry of Sience and Technology (Grant Numbers: 2021YFC2501802), National Natural Science Foundation of China (Grant Numbers: 82272189, 82072230), Natural Science Foundation of Guangdong Province (Grant Number: 2019A1515010206), Guangzhou Municipal Science and Technology Project (Grant Number: 202002030094) and High-level Hospital Construction Project (Grant Number: DFJH201804).

Author information

Authors and Affiliations

Authors

Contributions

YD and CC conceived and designed the experiments. NL performed the experiments. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Chunbo Chen or Yiyu Deng.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Consent to Participate

Informed consent was obtained from all individual participants included in the study.

Consent to Publish

The authors affirm that human research participants provided informed consent for the publication of the images in Table 1.

Ethical Approval

All animals were handled according to the protocols of the Institutional Animal Care and Use Committee, Guangdong Province, China (Animal Certificate No.: SYXK2012-0081). The human CSF specimen was conducted following the Declaration of Helsinki and was approved by the Research Ethics Committee of Guangdong Province’s General Hospital (KY-Q-2022-176-02).

Antibodies

We declared that a limitation in the study was the lack of testing of the specificity of the primary antibodies.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

10571_2023_1378_MOESM1_ESM.tif

Supporting Fig.1 A chart to describe different treatments for astrocyte or BV2 cells in each group. a, b. In the LPS+mimic-NC or LPS+mimic-miR-338-3p group, astrocytes and BV2 cells were first treated with 50nM mimic-NC or mimic-miR-338-3p for 24h, and then astrocytes were treated with LPS for 24h, and BV2 cells were treated with LPS for 6h. c, d. In the LPS+mimic-miR-338-3p+plasmid-STAT1 group, astrocytes and BV2 cells were first transfected with 50nM mimic-miR-338-3p and 0.8μg plasmid-STAT1 for 48h, then astrocytes were administrated with LPS for 24h and BV2 cells were administrated with LPS for 6h. e, f. In the LPS+si-NC or LPS+si-STAT1 group, astrocytes and BV2 cells were first transfected with 50nM si-NC or si-STAT1 for 24h, then astrocytes were administrated with LPS for 24h and BV2 cells were administrated with LPS for 6h. (TIF 3249 KB)

Supplementary file2 (PDF 4140 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, N., Zhou, Q., Wang, H. et al. MiRNA-338-3p Inhibits Neuroinflammation in the Corpus Callosum of LCV-LPS Rats Via STAT1 Signal Pathway. Cell Mol Neurobiol 43, 3669–3692 (2023). https://doi.org/10.1007/s10571-023-01378-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-023-01378-w

Keywords

Navigation